This can cause the immune response that leads to eczema symptoms. Some specific problems with a part of the immune system called the adaptive immune system probably also contribute to the disease.

Significantly more patients receiving dupilumab versus placebo, with or without asthma and allergic rhinitis (AR), achieved an Investigator’s Global Assessment (IGA) score of 0/1 and a ≥75 percent ...

The researchers found that at week 16, significantly more patients receiving dupilumab versus placebo, with or without asthma and allergic rhinitis (AR), achieved an Investigator’s Global Assessment ...

Eczema is not contagious ... In some cases, they can radically improve symptoms. Dupixent (dupilumab) was the first biologic treatment approved for atopic dermatitis. It became available in ...

It is formulated as an injectable solution for subcutaneous route of administration. Dupilumab is indicated for the treatment of asthma, atopic dermatitis (atopic eczema), nasal polyps (nasal ...

KKH has so far treated more than 250 children and adolescents with dupilumab. One of them, five-year-old Faris Zafran, was recommended Dupixent when he was in hospital for a bad eczema flare-up ...

Some examples of biologics that are used to treat eczema are Dupixent (dupilumab) or Ebglyss (lebrikizumab). Dupixent is FDA approved for adults and children 6 months and older who are suffering ...